Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers

被引:0
|
作者
Fan, Hua-Ping [1 ]
Zhou, Yu [1 ]
Chen, Mei-Li [2 ]
Qiu, Kun-Hua [3 ]
Feng, Xue [1 ]
Zhou, Chao [1 ]
Zhu, Min-Li [4 ]
Huang, Rong-Zhong [5 ]
Hu, Tian-Yang [5 ]
机构
[1] 63650 Mil Hosp, Dept Cardiol, Xinjiang, Peoples R China
[2] 63650 Mil Hosp, Dept Respirol & Gastroenterol, Xinjiang, Peoples R China
[3] 63650 Mil Hosp, Dept Prevent Med, Xinjiang, Peoples R China
[4] Special Med Ctr Strateg Support Force, Dept Resp Med, Beijing, Peoples R China
[5] Chongqing Med Univ, Affiliated Hosp 2, Precis Med Ctr, 74 Linjiang Rd, Chongqing 400010, Peoples R China
来源
PHARMACOTHERAPY | 2024年 / 44卷 / 07期
关键词
acute kidney injury; histamine-2 receptor antagonists; proton pump inhibitors; sepsis; stress ulcer prophylaxis; INTERNATIONAL CONSENSUS DEFINITIONS; CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; SEPSIS; FAILURE;
D O I
10.1002/phar.2947
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundTo compare the effects of proton pump inhibitor (PPI) and histamine-2 receptor antagonist (H2RA) use on the occurrence of acute kidney injury (AKI) in septic patients at high risk for developing stress ulcers.MethodsUsing the Medical Information Mart for Intensive Care IV version 2.2 database, septic patients with high-risk factors for stress ulcers (i.e., shock, coagulopathy, invasive mechanical ventilation, or chronic liver diseases) were included. Exposures included PPIs and H2RAs within 24 h of intensive care unit (ICU) admission or prior to ICU admission. The primary end point was severe sepsis-associated AKI as defined by the Kidney Disease Improving Global Outcomes criteria stage 3 (KDIGO-3). Propensity score matching (PSM) was performed to balance baseline characteristics. Multivariable Cox proportional hazards regression was used to estimate the effect size.Results4731 PPI users and 4903 H2RA users were included. After PSM, there were 1785 pairs exposed to PPIs and H2RAs. In the PSM cohort, the cumulative incident KDIGO-3 rate was higher in the PPI group than in the H2RA group (log-rank test, p = 0.009). Regression analyses showed that PPI exposure [adjusted hazard ratio 1.32, 95% confidence interval (CI) 1.11-1.58, p = 0.002] was associated with incident KDIGO-3 compared with H2RA use. This association remained consistent in sensitivity analyses. Additionally, the PPI group had a higher need for kidney replacement therapy compared with the H2RA group (3.6% vs. 2.1%, P = 0.012).ConclusionsAmong septic patients at high risk for developing stress ulcers, PPI exposure was associated with incident KDIGO-3 AKI compared with H2RA use.
引用
收藏
页码:539 / 548
页数:10
相关论文
共 50 条
  • [1] Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke
    Momosaki, Ryo
    Yasunaga, Hideo
    Matsui, Hiroki
    Fushimi, Kiyohide
    Abo, Masahiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (05): : 1035 - 1040
  • [2] Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and the Risk of Kidney Stones: Negligible or Not?
    Pella, Eva
    Chalkidou, Maria
    Sarafidis, Pantelis
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (03) : 624 - 625
  • [3] Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
    Kweon, Takhyeon
    Kim, Yerim
    Lee, Kyung Joo
    Seo, Won-Woo
    Seo, Seung In
    Shin, Woon Geon
    Shin, Dong Ho
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [4] Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
    Takhyeon Kweon
    Yerim Kim
    Kyung Joo Lee
    Won-Woo Seo
    Seung In Seo
    Woon Geon Shin
    Dong Ho Shin
    Scientific Reports, 13 (1)
  • [5] Concerning Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists
    Xie, Jian
    Li, Lang
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (10):
  • [6] Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis
    Vangala, Chandan
    Niu, Jingbo
    Lenihan, Colin R.
    Mitch, William E.
    Navaneethan, Sankar D.
    Winkelmayer, Wolfgang C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1534 - 1541
  • [7] Concerning Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists Reply
    Pereg, David
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (10):
  • [8] Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients
    Corley, Douglas A.
    Kubo, Ai
    Zhao, Wei
    Quesenberry, Charles
    GASTROENTEROLOGY, 2010, 139 (01) : 93 - 101
  • [9] Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis
    Sadaka, Farid
    Trottier, Steven
    Smith, Timothy
    VanSlette, Jeffrey
    Kasal, Jan
    Palagiri, Ashok
    Subramanian, Sanjay
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [10] Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia
    Nagahara, Akihito
    Asaoka, Daisuke
    Hojo, Mariko
    Oguro, Masako
    Shimada, Yuji
    Ishikawa, Dai
    Osada, Taro
    Kawabe, Masato
    Yoshizawa, Takashi
    Otaka, Michiro
    Watanabe, Sumio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : S122 - S128